gemfibrozil has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tugnait, M | 1 |
| Gupta, N | 1 |
| Hanley, MJ | 1 |
| Sonnichsen, D | 1 |
| Kerstein, D | 1 |
| Dorer, DJ | 1 |
| Venkatakrishnan, K | 1 |
| Narasimhan, N | 1 |
1 trial available for gemfibrozil and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers.
Topics: Administration, Oral; Adult; Aged; Anaplastic Lymphoma Kinase; Area Under Curve; Carcinoma, Non-Smal | 2020 |